Phase I trial of adjuvant mature autologous dendritic cell/allogeneic tumor lysate vaccines in combination with temozolomide in newly diagnosed glioblastoma (Jun 2022)
Hydrogel supplemented with human platelet lysate enhances multi-lineage differentiation of mesenchymal stem cells (Apr 2022)
Human meniscus allograft augmentation by allogeneic mesenchymal stromal/stem cell injections (Mar 2022)
CELLTOP Clinical Trial: First Report From a Phase 1 Trial of Autologous Adipose Tissue Derived Mesenchymal Stem Cells in the Treatment of Paralysis Due to Traumatic Spinal Cord Injury (Feb 2020)